Zenith Drugs Ltd
₹39.95
(3.90%)
Mon, 06 Apr 2026, 06:37 pm
Health Technology
Pharmaceuticals: Major
24.5KZenith Drugs Price to Cash Flow Ratio
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 1.73 | 1.56 | 1.51 | 0.38 | 0.70 |
| Return on equity % | 0 | 29.83 | 35.13 | 24 | 10.88 |
Zenith Drugs Ltd Price to Cash Flow Ratio
The Zenith Drugs Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Zenith Drugs Ltd's valuation, profitability, and overall financial performance. Tracking the Zenith Drugs Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Zenith Drugs Ltd (NSE: ZENITHDRUG, BSE: 92356) is currently trading at ₹39.95, with a market capitalization of ₹653.37M. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Zenith Drugs Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Zenith Drugs Ltd Price to Cash Flow Ratio Current Value
The current Zenith Drugs Ltd Price to Cash Flow Ratio stands at 0.
The Zenith Drugs Ltd Price to Cash Flow Ratio remains stable, indicating consistent financial performance.
Zenith Drugs Ltd Price to Cash Flow Ratio Historical Trend
The Zenith Drugs Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 0
The decline in Zenith Drugs Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Zenith Drugs Ltd Price to Cash Flow Ratio Indicates for Investors
The Zenith Drugs Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Zenith Drugs Ltd Price to Cash Flow Ratio Analysis Summary
The Zenith Drugs Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Zenith Drugs Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Zenith Drugs Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800